ReviewEuropean respiratory review : an official journal of the European Respiratory Society2017
Screening for COPD: the gap between logic and evidence.
Review in European respiratory review : an official journal of the European Respiratory Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
36 citing papers in PubMed, 59 citations in OpenAlex.
- Risk-stratified early intervention for paucisymptomatic GOLD I-II chronic obstructive pulmonary disease: breaking the diagnostic deadlock.Journal of thoracic disease · 2026Article
- Identification and treatment of GOLD stages I and II chronic obstructive pulmonary disease.Journal of thoracic disease · 2026Article
- Lung Function and Respiratory Symptoms as Factors Associated with Smoking Cessation Status in a Population-Based Study.Journal of clinical medicine · 2026Article
- Early warning and stratification of the elderly cardiopulmonary dysfunction-related diseases: multicentre prospective study protocol.BMJ open · 2025Article
- Pragmatic Evaluation of an Improvement Program for People Living With Modifiable High-Risk COPD Versus Usual Care: Protocols for the Cluster Randomized PREVAIL Trial.Chronic obstructive pulmonary diseases (Miami, Fla.) · 2025Article
- Dynamic performance and scenario-based screening strategy of six COPD questionnaires: a cross-sectional study with prevalence-driven robustness validation.Frontiers in medicine · 2025Article
- Global respiratory health priorities at the beginning of the 21st century.European respiratory review : an official journal of the European Respiratory Society · 2024Review
- How will lung cancer screening and lung nodule management change the diagnostic and surgical lung cancer landscape?European respiratory review : an official journal of the European Respiratory Society · 2024Review
- Feasibility and performance of the chronic obstructive pulmonary disease population screener and chronic obstructive pulmonary disease screening questionnaire in a Chinese physical examination center.Journal of thoracic disease · 2024Article
- Evaluating the Effectiveness of the COPD Assessment Test (CAT) in Screening for Chronic Obstructive Pulmonary Disease.International journal of chronic obstructive pulmonary disease · 2024Article
- Prevalence and Risk Factors of Chronic Obstructive Pulmonary Disease Among Users of Primary Health Care Facilities in Morocco.International journal of chronic obstructive pulmonary disease · 2024Observational
- Screening and early diagnosis of chronic obstructive pulmonary disease: a population study.BMC pulmonary medicine · 2023Article
- Quantitative CT Analysis Based on Smoking Habits and Chronic Obstructive Pulmonary Disease in Patients with Normal Chest CT.Journal of the Korean Society of Radiology · 2023Article
- Most patients with COPD are unaware of their health threats and are not diagnosed: a national-level study using pulmonary function test.Scientific reports · 2023Article
- Comparison of newly diagnosed COPD patients and the non-COPD residents in Shanghai Minhang District.Frontiers in public health · 2023Article
- Efficacy of a Self-Designed Questionnaire for Community Screening of COPD.International journal of chronic obstructive pulmonary disease · 2022Article
- COPD - do the right thing.BMC family practice · 2021Review
- Novel App-Based Portable Spirometer for the Early Detection of COPD.Diagnostics (Basel, Switzerland) · 2021Article
- Dyspnoea and symptom burden in mild-moderate COPD: the Canadian Cohort Obstructive Lung Disease Study.ERJ open research · 2021Article
- Underestimation of respiratory symptoms by smokers: a thorn in chronic obstructive pulmonary disease diagnosis.NPJ primary care respiratory medicine · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic obstructive pulmonary disease (COPD) is a common disease leading to further morbidity and significant mortality. The first step for any condition is to make the appropriate diagnosis, and spirometry barriers abound in practice around the world. It is tempting to undertake mass screening on all smokers to detect COPD. While this would pick up cases of COPD, results of studies of its effect on COPD end-points such as exacerbations, hospitalisations and mortality are disappointing. As such, aggressive case finding of COPD by screening for symptoms that patients may not themselves perceive is very important in primary care, with subsequent spirometry defining the diagnosis.We also have to separate out population screening from individual patient interactions. Performing spirometry, even on a truly asymptomatic patient, may allow earlier diagnosis and modification of risk factors such as smoking (mostly) and exacerbation risk. It also recognises patients with early disease who are at high risk of comorbidities such as cardiac illness, such that appropriate treatment strategies can be implemented. Making a diagnosis, and even the fact of worrying about such a diagnosis, can affect the motivational level of the individual patient to cease smoking; all patients should of course be counselled to stop smoking. As such, consider the individual patient in front of you for unrecognised symptoms and therefore unrecognised illness, as making a diagnosis earlier can allow the institution of care, including smoking cessation, vaccination, bronchodilators and comorbidity management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.